1. Tumor Necrosis Factor Receptor-2 Signals Clear-Cell Renal Carcinoma Proliferation via Phosphorylated 4E Binding Protein-1 and Mitochondrial Gene Translation
   Rafia S. Al-Lamki et al, 2024, The American Journal of Pathology CrossRef
2. The complex interplay between redox dysregulation and mTOR signaling pathway in cancer: A rationale for cancer treatment
   Christophe Glorieux et al, 2025, Biochemical Pharmacology CrossRef
3. The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications
   Seyed Hossein Shahcheraghi et al, 2022, Medical Oncology CrossRef
4. Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma
   Maria Vittoria Marvi et al, 2022, Advances in Biological Regulation CrossRef
5. Upregulation of glutamate transporter 1 by mTOR/Akt pathway in astrocyte culture during oxygen–glucose deprivation and reoxygenation
   Mi Li et al, 2023, Experimental Brain Research CrossRef
6. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets
   Meena Jhanwar-Uniyal et al, 2024, Cells CrossRef
7. Defining the role of mTOR pathway in the regulation of stem cells of glioblastoma
   Meena Jhanwar-Uniyal et al, 2023, Advances in Biological Regulation CrossRef
8. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
   Brittany Dewdney et al, 2023, Signal Transduction and Targeted Therapy CrossRef
9. Synthesis, biological screening, and binding mode analysis of some N-substituted tetrahydroquinoline analogs as apoptosis inducers and anticancer agents
   Rajdeep Dey et al, 2024, Journal of Molecular Structure CrossRef
10. Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma
    Hao Wu et al, 2022, Frontiers in Molecular Neuroscience CrossRef
11. The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches
    Murat Ihlamur et al, 2024, Current Molecular Medicine CrossRef
12. Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells
    Dana Hellmold et al, 2023, International Journal of Molecular Sciences CrossRef
13. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma
    Meena Jhanwar-Uniyal et al, 2022, Advances in Biological Regulation CrossRef
14. A cross-disease resource of living human microglia identifies disease-enriched subsets and tool compounds recapitulating microglial states
    John F. Tuddenham et al, 2024, Nature Neuroscience CrossRef